TCFVP16 expression led to strongly boosted positive WNT-TCF target gene levels in colon cancer cells, shown as ratios of those in Ivermectin-treated TCFVP16 cells over those in Ivermectin-treated control cells (Fig5B). The gene discussed is HNF4A; the disease is colonic neoplasm.